Global Pleurodynia Treatment Market Poised for Substantial Growth: Economic Development and Infrastructure Boost Expansion
October 04, 2023 06:03 ET
|
Research and Markets
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Pleurodynia Treatment Market by Diagnosis (Blood Test, Culture Test, X-ray), Treatment (Analgesics, Immunoglobulin), Mode Of Administration,...
Global BREO Ellipta Drugs Research Report 2023-2031 Featuring Major Players - GSK, Akros Pharma, Sun Pharmaceutical Industries, Gilead Sciences, Abbott, & Genosco
October 02, 2023 07:38 ET
|
Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Global BREO Ellipta Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global BREO ellipta...
High Prevalence of RSV in Infants and Elderly Pushes RSV Vaccine and Antibody Market Growth - Forecast to 2030
September 28, 2023 04:58 ET
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Forecast up to 2030" report has been added to ResearchAndMarkets.com's...
Leading Companies like Roche and Novartis at the Helm of the Global Rapidly Expanding IPF Treatment Market to 2030
September 26, 2023 05:23 ET
|
Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:24 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:22 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:19 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
AstraZeneca, Pfizer Inc., and Novartis AG Spearhead Innovation in Tuberculosis Therapeutics Amid Rising Global Prevalence
July 20, 2023 05:18 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Active TB, Latent TB), By Therapy, By Route Of...
Global Idiopathic Pulmonary Fibrosis (IPF) Market to 2029: Players Include Boehringer Ingelheim, F. Hoffmann-La Roche, Cipla and Shionogi & Co
July 13, 2023 04:33 ET
|
Research and Markets
Dublin, July 13, 2023 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration...
Global Asthma & COPD Therapies Market Report 2023-2033: Expansion into Emerging Markets to Offer Lucrative Growth Opportunities
June 28, 2023 04:38 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Asthma & COPD Therapies Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Asthma & COPD Therapies Market...